Eli Lilly & Co.’s stock rose 1.6% Wednesday, after the drug company announced plans to expand its U.S. manufacturing sites by adding four more locations this year, along with 13,000 high-wage jobs.
From its origins in a garage to becoming one of the most recognisable symbols in the world, explore the story behind the iconic Apple logo design. Apple is a company that has changed the technology ...
While appearing on 'Not Gonna Lie with Kylie Kelce podcast,' the 'Running Point' star looked back on being typecast in those roles. By Lexy Perez Associate Editor “It’s a mixed feeling ...
In 2024, Cage starred in the highest grossing Neon film ever, Osgood Perkins’ “Longlegs.” The Oscar-winning actor will next lead David O. Russell’s ’70s-set biopic “Madden” about NFL ...
Chang later returned home on the same road where hours earlier he’d hit Lilly Glaubach. He spent one more night with his wife and daughter before police knocked on his door after a Good ...
A small Swiss biotech has terminated a mid-stage test of a new type of oral drug for people with Alzheimer’s disease, according to the federal … ...
Eli Lilly has launched new 7.5 mg and 10 mg single-dose vials of Zepbound (tirzepatide), priced at $499 per month under the newly introduced Zepbound Self Pay Journey Program. The company said ...
Walter Salles' feature won best international feature, taking home Brazil's first Oscar. By Georg Szalai Global Business Editor Director Walter Salles credited the woman who inspired the film ...
After taking home five Palme d’Or trophies in a row at the Cannes Film Festival, Neon has translated its second Croisette top prize, Anora, to an Oscar Best Picture win. The last time this ...
Eli Lilly (NYSE:LLY) recently announced its plans to invest $27 billion in four new U.S. manufacturing plants over the next five years, creating thousands of jobs. This move comes at a time when ...
Credit: shisu_ka/Shutterstock. Magnet Biomedicine has entered a partnership and licence agreement with Eli Lilly to discover, develop and commercialise oncology molecular glue therapeutics. The ...
Eli Lilly is set to keep growing its revenue at a strong pace in the next five years. The company is likely to add important medicines to its lineup. Eli Lilly's shares look attractive right now.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback